广州白云山医药集团股份有限公司（简称“白云山医药”）将于2025年12月30日上午10时在广州市荔湾区沙面北街45号公司会议室召开2025年第三次临时股东大会。议程包括审议“关于广州医药股份有限公司开展应收账款资产证券化业务”及“关于募集资金投资项目结项及节余募集资金永久补充流动资金”等议案。届时公司董事、高级管理人员及律师将出席。为确定H股股东出席资格，公司股份过户登记将于12月23日至12月30日暂停办理，有意参会者须提前在股东登记时间内完成手续。会议预计半天，交通食宿费用由与会者自理，并请记者事先登记。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.